It has been shown that the BRCA2-mutant in prostate cancer might be associated with the histological characteristics of intraductal carcinoma of the prostate (IDC-P), and a tendency for higher incidence of biochemical relapse after surgery. Here, BRCA2 is linked to prostate cancer.